← Eichor
Study identifier: NCT04359394 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

International Rare And Severe Psoriasis Expert Network

Condition: Pustular Psoriasis (PP)  ·  Sponsor: University Hospital, Basel, Switzerland

PhaseN/A
Planned participants180
Who can joinAll sexes, 6 Months to no upper limit
Healthy volunteersNo

About this study

This registry is a prospective observational study in order to describe primarily the natural course of PP subtypes and to gain detailed information about their phenotype.

This description comes directly from the study's public registry record.

Talk to the study team

Alexander Navarini, Prof. Dr. med. Dr. sc. nat.  ·  +41 61 328 60 80  ·  alexander.navarini@usb.ch

Always discuss trial participation with your own doctor first.

Locations (8)

Klinikum der Universität MünchenMünchen, GermanyRecruiting
Fondazione Policlinico Universitario "Agostino Gemelli" IRCCSRome, ItalyRecruiting
Universitário do PortoPorto, PortugalRecruiting
National Skin CentreSingapore, SingaporeRecruiting
Dermatology, University Hospital BaselBasel, SwitzerlandRecruiting
University Hospital ZürichZurich, SwitzerlandRecruiting
Akdeniz University School of Medicine; Department of Dermatology and VenereologyAntalya, Turkey (Türkiye)Recruiting
Trakya University, Faculty of Medicine; Department of Dermatology and VenereologyEdirne, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04359394